[go: up one dir, main page]

FR2623399B1 - PROCESS FOR PRODUCING ANTIGENS, VACCINES AND SERUMS AGAINST BACTERIAL OR VIRAL DISEASES AND COMPOSITION USED - Google Patents

PROCESS FOR PRODUCING ANTIGENS, VACCINES AND SERUMS AGAINST BACTERIAL OR VIRAL DISEASES AND COMPOSITION USED

Info

Publication number
FR2623399B1
FR2623399B1 FR8716207A FR8716207A FR2623399B1 FR 2623399 B1 FR2623399 B1 FR 2623399B1 FR 8716207 A FR8716207 A FR 8716207A FR 8716207 A FR8716207 A FR 8716207A FR 2623399 B1 FR2623399 B1 FR 2623399B1
Authority
FR
France
Prior art keywords
vaccines
composition used
viral diseases
against bacterial
producing antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8716207A
Other languages
French (fr)
Other versions
FR2623399A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR8716207A priority Critical patent/FR2623399B1/en
Priority to AU27134/88A priority patent/AU2713488A/en
Priority to PCT/FR1988/000568 priority patent/WO1989004869A1/en
Priority to EP19880910063 priority patent/EP0351426A1/en
Publication of FR2623399A1 publication Critical patent/FR2623399A1/en
Application granted granted Critical
Publication of FR2623399B1 publication Critical patent/FR2623399B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16763—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8716207A 1987-11-23 1987-11-23 PROCESS FOR PRODUCING ANTIGENS, VACCINES AND SERUMS AGAINST BACTERIAL OR VIRAL DISEASES AND COMPOSITION USED Expired - Lifetime FR2623399B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR8716207A FR2623399B1 (en) 1987-11-23 1987-11-23 PROCESS FOR PRODUCING ANTIGENS, VACCINES AND SERUMS AGAINST BACTERIAL OR VIRAL DISEASES AND COMPOSITION USED
AU27134/88A AU2713488A (en) 1987-11-23 1988-11-23 Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process
PCT/FR1988/000568 WO1989004869A1 (en) 1987-11-23 1988-11-23 Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process
EP19880910063 EP0351426A1 (en) 1987-11-23 1988-11-23 Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8716207A FR2623399B1 (en) 1987-11-23 1987-11-23 PROCESS FOR PRODUCING ANTIGENS, VACCINES AND SERUMS AGAINST BACTERIAL OR VIRAL DISEASES AND COMPOSITION USED

Publications (2)

Publication Number Publication Date
FR2623399A1 FR2623399A1 (en) 1989-05-26
FR2623399B1 true FR2623399B1 (en) 1990-12-28

Family

ID=9357062

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8716207A Expired - Lifetime FR2623399B1 (en) 1987-11-23 1987-11-23 PROCESS FOR PRODUCING ANTIGENS, VACCINES AND SERUMS AGAINST BACTERIAL OR VIRAL DISEASES AND COMPOSITION USED

Country Status (4)

Country Link
EP (1) EP0351426A1 (en)
AU (1) AU2713488A (en)
FR (1) FR2623399B1 (en)
WO (1) WO1989004869A1 (en)

Also Published As

Publication number Publication date
EP0351426A1 (en) 1990-01-24
WO1989004869A1 (en) 1989-06-01
FR2623399A1 (en) 1989-05-26
AU2713488A (en) 1989-06-14

Similar Documents

Publication Publication Date Title
FR2541116B1 (en) PROCESS FOR THE PREPARATION OF VERSATILE VACCINES (TETANOS, DIPHTERIA, COQUELUCHE) LYOPHILIZED ADSORBES
AU2641588A (en) Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
EP0149040A3 (en) Modified live pseudorabies viruses, vaccines for pseudorabies disease containing same, methods for production of same and methods for use of same
PH25120A (en) Replicable expression vehicle and process of preparation thereof
NZ211880A (en) Immunogenic, leukemia-associated viral proteins and vaccines
FR2594846B1 (en) PROCESS FOR THE PREPARATION OF MATURE HUMAN ALBUMIN SERUM
AU1347688A (en) Viral antigen, process for its production, and application in diagnosis and therapy (vaccine)
FR2563434B1 (en) Rabies vaccine and process for its preparation
PT75364A (en) PROCESS FOR THE PREPARATION OF ORAL VACCINE FOR IMMUNIZATION AGAINST ENTERIC DISEASES AND GENETIC HYBRID DERIVATIVE SUITABLE FOR PREPARATION
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
FR2599626B1 (en) FLAVIVIRUS ANTIGEN, METHOD FOR THE PRODUCTION THEREOF AND VACCINE CONTAINING THE SAME
EP0006035A3 (en) Bacterial beta-galactosidase, immobilized forms thereof, process for their preparation and use in the hydrolysis of lactose, and novel bacteria
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
NO180181C (en) Process for the preparation of an ice-nucleating protein, plasmids and bacterial strains
DE3160264D1 (en) Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines
AU2192588A (en) Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
AU591901B2 (en) Process for the in vitro immunization of human splenocytes against tumor associated antigens
IL71953A (en) Malaria associated antigen,process for preparation thereof and vaccine comprising it
NZ213249A (en) Protein antigen, dna, plasmid, transformed microorganism and influenza vaccine
FR2623399B1 (en) PROCESS FOR PRODUCING ANTIGENS, VACCINES AND SERUMS AGAINST BACTERIAL OR VIRAL DISEASES AND COMPOSITION USED
AU616667B2 (en) Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use
AU636529B2 (en) Methods and compositions for the production of haemophilus influenzae type b major outer membrane protein antigens
GB8813095D0 (en) Palatinose condensation product & process for preparation thereof & method for utilizing product
FR2612519B1 (en) NOVEL PEPTIDE FRACTIONS INDUCING PROTECTIVE ANTIBODIES AGAINST BOVINE LEUKEMIA VIRUS, PROCESS FOR OBTAINING SUCH FRACTIONS, THEIR ENCODING SEQUENCES AND VACCINES MADE FROM SUCH FRACTIONS

Legal Events

Date Code Title Description
ST Notification of lapse